beta-hydroxyisovaleric acid has been researched along with Hearing Loss, Sensorineural in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrozzo, R; Dionisi-Vici, C; Joensen, F; Kluijtmans, LA; Morava, E; Santer, R; Steuerwald, U; Wevers, RA | 1 |
| de Koning, T; Engelke, U; Huizing, M; Kluijtmans, LA; Loupatty, FJ; Morava, E; Rodenburg, RJ; Smeitink, JA; Wevers, R; Wortmann, S | 1 |
2 other study(ies) available for beta-hydroxyisovaleric acid and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; Dystonia; Hearing Loss, Sensorineural; Homozygote; Humans; Infant; Lactates; Male; Metabolic Networks and Pathways; Methylmalonic Acid; Models, Biological; Succinate-CoA Ligases; Valerates; Young Adult | 2009 |
Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation.
Topics: Adolescent; Brain Diseases, Metabolic; Child; Child, Preschool; Consanguinity; Fatal Outcome; Female; Glutarates; Hearing Loss, Sensorineural; Humans; Infant, Newborn; Leigh Disease; Male; Mitochondrial Diseases; Oxidative Phosphorylation; Syndrome; Valerates | 2006 |